Charles Elliott Sigal Insider Profile
4 Followers
Charles Elliott Sigal, Director at Alnylam Pharma, holds 5.05K shares in Alnylam Pharma (Ticker: ALNY), holds 49.81K shares in Vir Biotechnology (Ticker: VIR), holds 0.00 shares in Surface Oncology (Ticker: SURF). Most recently, Charles Elliott Sigal Bought ― shares of Alnylam Pharma on Nov 12, 2026 for an estimated value of $243.60K.
Charles Elliott Sigal's Trading History
You May Also Like
Charles Elliott Sigal insider profile FAQ
What is the percentage of profitable transactions made by Charles Elliott Sigal?
The percentage of profitable transactions made by Charles Elliott Sigal is 33%.
What is the average return per transaction made by Charles Elliott Sigal?
The average return per transaction made by Charles Elliott Sigal is -26.70%.
What stocks does Charles Elliott Sigal hold?
Charles Elliott Sigal holds: ALNY, ADAPY, SURF, VIR stocks.
What was Charles Elliott Sigal’s latest transaction?
Charles Elliott Sigal’s latest transaction was an Informative Buy of $243.60K.
What was Charles Elliott Sigal's most profitable transaction?
Charles Elliott Sigal’s most profitable transaction was an Informative Buy of ALNY stock on November 12, 2026. The return on the trade was 5.30%.
What is Charles Elliott Sigal's role in Alnylam Pharma?
Charles Elliott Sigal's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
